Protein kinase C and chemical-induced abnormal palate development

Human and Experimental Toxicology

Volumn 24, Issue 4, 2005, Pages 203-214

  Reddy, Chada S ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

Cleft palate; Development; Protein kinase C; Secalonic acid D

Indexed keywords

GROWTH FACTOR; LIGAND; MYCOTOXIN; PROTEIN KINASE C; SECALONIC ACID D; TRANSCRIPTION FACTOR;

ANIMAL CELL; APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TYPE; CHEMICAL TERATOGENESIS; CONTROLLED STUDY; EARLY DIAGNOSIS; EMBRYO DEVELOPMENT; ENZYME ANALYSIS; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; GENE SEQUENCE; KNOCKOUT GENE; LIGAND BINDING; MESENCHYME; MOUSE; NONHUMAN; PALATE MALFORMATION; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; REVIEW;

ABNORMALITIES, DRUG-INDUCED; CLEFT PALATE; FACE; HUMANS; PALATE; PROTEIN KINASE C; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION; XANTHONES;

EID: 20144364609     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1191/0960327105ht515oa     Document Type: Review

References (95)

1. Newton AC. Protein kinase C: structural and spatial regulation by phosphorylation, cofactors and macromolecular interactions. Chem Rev 2001; 101: 2353-64.
2. Shirai Y, Saito N. Activation mechanisms of protein kinase C: maturation, catalytic activation, and targeting. J Biochem 2002; 132: 663-68.
3. Angel P, Imagawa M, Chiu R, Stein B, Imbra RJ, Rahmsdorf HJ et al. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 1987; 49: 729-39.
4. Boulikas T. Phosphorylation of transcription factors and control of the cell cycle. Crit Rev Eukaryot Gene Expression 1995; 5: 1-77.
5. Karin M, Zheng-gang I, Ebrahim Z. AP-1 function and regulation. Curr Opin Cell Biol 1997; 9: 240-46.
6. Angel P, Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1991; 1072: 129-57.
7. Vogt PK, Bos TJ. Jun: oncogene and transcription factor. Adv Cancer Res 1990; 55: 1-35.
8. Masquilier D, Sassone-Corsi P. Transcriptional cross-talk: nuclear factors CREM and CREB bind to AP-1 sites and inhibit activation by Jun. J Biol Chem 1992; 267: 22460-66.
9. Hai T, Curran T. Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc Natl Acad Sci USA 1991; 88: 3720-3724.
10. Chakravarti D, LaMorte VJ, Nelson MC, Nakajima T, Schulman IG, Juguilon H, Montminy M, Evans RM. Role of CBP/P300 in nuclear receptor signalling. Nature 1996; 383: 99-103.
11. Kawasaki H, Eckner R, Yao TP, Taira K, Chiu R, Livingston DM, Yokoyama KK. Distinct roles of the coactivators p300 and CBP in retinoic-acid-induced F9-cell differentiation. Nature 1998; 393: 284-89.
12. Verma IM, Sassone-Corsi P. Proto-oncogene fos: complex but versatile regulation. Cell 1987; 51: 513-14.
13. Gunther KE, Ramkissoon S, Lydan MA, O'Day DH. Fertilization in Dictyostelium: pharmacological analyses and the presence of a substrate protein suggest protein kinase C is essential for gamete fusion. Exp Cell Res 1995; 220: 325-31.
14. Gallicano GI, Yousef MC, Capco DG. PKC: a pivotal regulator of early development. Bioessays 1997; 19: 29-36.
15. Grandin N, Charbonneau M. Intracellular pH and free Ca+ + responses to protein kinase C activators and inhibitors in Xenopus eggs. Integr Annu Index 1991; 112: 461-70.
16. Shyu JC, Hsieh YS, Chang CL, Tsai CC, Liu HC, Chang AC, Yang LC, Lin LY, Liu JY. Protein kinase C isoforms during the development of deciduomata in pregnant rats. Life Sci 1999; 64: 2367-73.
17. Winkel GJ, Ferguson JE, Takeichi M, Nuccitelli R. Activation of protein kinase C triggers premature compaction of the four-cell stage mouse embryo. Dev Biol 1990; 138: 1-15.
18. Tabuse Y, Izumi Y, Piano F, Kemphues KJ, Miwa J, Ohno S. Atypical protein kinase C cooperates with PAR-3 to establish embryonic polarity in C. elegans. Development 1998; 125: 3607-14.
19. Gelman IH, Tombler E, Vargas J Jr. A role for SSeCKS, a major protein kinase C substrate with tumor suppressor activity, in cytoskeletal architecture, formation of migratory processes and cell migration during embryogenesis. Histochem J 2000; 32: 13-26.
20. Otte AP, Coster CH, Snoek GT, Durston AJ. Protein kinase C mediates neural induction in Xenopus laevis. Nature 1988; 334: 618-20.
21. Pauken CM, Capco DG. The expression and stage-specific localization of protein kinase C isotypes during preimplantation development. Dev Biol 2000; 223: 411-21.
22. Horne-Badovinac S, Lin D, Waldron S, Schwarz M, Mbamalu G, Pawson T, Jan Y, Stainier DY, Abdelilah-Seyfried S. Positional cloning of the heart and soul reveals multiple roles for PKC lambda in zebrafish organogenesis. Curr Biol 2001; 11: 1492-502.
23. Yang MS, Chang SH, Sonn JK, Lee LS, Kang SS, Park TK et al. Regulation of chondrogenic differentiation of mesenchymes by protein kinase C alpha. Mol Cells 1998; 8: 266-71.
24. Clerk A, Bogoyevitch MA, Fuller SJ, Lazou A, Parker PJ, Sugden PH. Expression of protein kinase C isoforms during cardiac ventricular development. Am J Physiol 1995; 269: H1087-97.
25. Bareggi R, Grill V, Zweyer M, Narducci P, Martelli AM. Distribution of the extended family of protein kinase C isoenzymes in fetal organs of mice: an immunohistological study. Cell Tissue Res 1995; 280: 617-25.
26. Serlachius E, Swennilson J, Schalling M, Aperia A. Protein kinase C in the developing kidney: isoform expression and effects of ceramide and PKC inhibitors. Kidney Int 1997; 52: 901-10.
27. Mangoura D, Sogos V, Dawson G. Protein kinase C epsilon is a developmentally regulated neuronal isoform in the chick embryo nervous system. J Neurosci Res 1990; 35: 488-98.
28. Miki A. Developmental expression of alpha-, beta- and gamma-subspecies of protein kinase C in the dorsal corticospinal tract in the rat spinal cord. Neuroscience 1996; 75: 939-48.
29. Hess L, Chamberlin T, Ciment G. Changes in protein kinase C activities are correlated with the metaplastic transformation of Schwann cell precursors of avian embryos into melanocytes. J Neurosci Res 1988; 21: 101-106.
30. Powell EM, Mercado ML, Calle-Patino Y, Geller HM. Protein kinase C mediates neurite guidance at an astrocyte boundary. Glia 2001; 33: 288-97.
31. Schrenk K, Kapfhammer JP, Metzger F. Altered dendritic development of cerebellar Purkinje cells in slice cultures from protein kinase C gamma-deficient mice. Neuroscience 2002; 110: 675-89.
32. Paylor R, Baskall-Baldini L, Yuva L, Wehner JM. Developmental differences in place-learning performance between C57BL/6 and DBA/2 mice parallel the ontogeny of hippocampal protein kinase C. Behav Neurosci 1996; 110: 1415-25.
33. Nakashima S. Protein kinase Cα (PKC δ): regulation and biological function. J Biochem 2002; 132: 669-75.
34. Leitges M, Plomann M, Standaert ML, Bandyopadhyay G, Sajan MP, Kanoh Y, Farese RV. Knockout of PKC δ enhances insulin signalling through PI3K. Molec Endocrinol 2002; 16: 847-58.
35. Leitges M, Schmedt C, Guinamard R, Davoust J, Schaal S, Stabel S, Tarakhovsky A. Immunodeficiency in protein kinase c beta-deficient mice. Science 1996; 273: 788-91.
36. Moscat J, Diaz-Meco MT, Rennert P. NF-κB activation by protein kinase C isoforms and B cell function. EMBO Rep 2003; 4: 31-36.
37. Abeliovich A, Chen C, Goda Y, Silva AJ, Stevens CF, Tonegawa S. Modified hippocampal long-term potentiation in PKC γ-mutant mouse. Cell 1993; 75: 1253-62.
38. Saito N, Shirai Y. Protein kinase γ (PKC γ): function of neuron specific isotype. J Biochem 2002; 132: 683-87.
39. Kikkawa U, Matsuzaki H, Yamamoto T. Protein kinase C δ (PKC δ): activation mechanisms and functions. J Biochem 2002; 132: 831-39.
40. Miyamoto A, Nakayama K, Imaki H, Hirose S, Jiang Y, Abe M, Tsukiyama T, Nagahama H, Ohno S, Hatakeyama S, Nakayama KI. Increased proliferation of B cells and auto-immunity in mice lacking protein kinase c [delta]. Nature 2002; 416: 865-69.
41. Akita Y. Protein kinase C ε (PKC ε): its unique structure and function. J Biochem 2002; 132: 847-52.
42. Altman A, Villalba M. Protein kinase C θ (PKCθ): a key enzyme in T cell life and death. J Biochem 2002; 132: 841-46.
43. Kashiwagi M, Ohba M, Kazuhiro C, Toshio T. Protein kinase C η (PKCη): its involvement in keratinocyte differentiation. J Biochem 2002; 132: 853-57.
44. Hirai T, Kazuhiro C. Protein kinase C ζ (PKCζ): activation mechanisms and cellular functions. J Biochem 2003; 133: 1-7.
45. Suzuki A, Akimoto K, Ohno S. Protein kinase C λ/ι (PKCλ/ι): a PKC isotype essential for the development of multicellular organisms. J Biochem 2003; 133: 9-16.
46. Fujinaga M, Park HW, Shepard TH, Mirkes PE, Baden JM. Staurosporine does not prevent adrenergic-induced situs in versus, but causes a unique syndrome of defects in rat embryos grown in culture. Teratology 1994; 50: 261-74.
47. Ward KW, Rogers EH, Hunter ES 3rd. Dysmorphogenic effects of a specific protein kinase C inhibitor during neurulation. Reprod Toxicol 1998; 12: 525-34.
48. Wentzel P, Wentzel CR, Gareskog MB, Eriksson UJ. Induction of embryonic dysmorphogenesis by high glucose concentration, disturbed inositol metabolism and inhibited protein kinase C activity. Teratology 2001; 63: 193-201.
49. Stumpo DJ, Bock CB, Tuttle JS, Blackshear PJ. MARCKS deficiency in mice leads to abnormal brain development and perinatal death. Proc Natl Acad Sci USA 1995; 92: 944-48.
50. Francis-West P, Ladher R, Barlow A, Graveson A. Signalling interactions during facial development. Mech Dev 1998; 75: 3-28.
51. Vieille-Grosjean I, Hunt P, Gulisano M, Boncinelli E, Thorogood P. Branchial Hox gene expression and craniofacial development. Dev Biol 1997; 183: 49-60.
52. ElDeib MMR, Reddy CS. Secalonic acid D-induced changes in palatal cyclic AMP and cyclic GMP in developing mice. Teratology 1988; 37: 343-52.
53. Potchinsky MB, Lloyd MR, Weston WM, Greene RM. Selective modulation of MAP kinase in embryonic palate cells. J Cell Physiol 1998; 176: 266-80.
54. Greene RM, Linask KK, Pisano MM, Weston WM, Lloyd MR. Transmembrane and intracellular signal transduction during palatal ontogeny. J Craniofac Genet Dev Biol 1991; 11: 262-76.
55. Weston WM, Potchinsky MB, Lafferty CM, Ma L, Greene RM. Cross-talk between signalling pathways in murine embryonic palate cells: effect of TGF beta and cAMP on EGF-induced DNA synthesis. In Vitro Cell Dev Biol 1998; 34: 74-78.
56. Pratt RM, Kim CS, Grove RI. Role of glucocorticoids and EGF in normal and abnormal palate development. Curr Top Dev Biol 1984; 19: 81-101.
57. Silver MH, Murray JC, Pratt RM. EGF stimulates type-V collagen synthesis in cultured murine palates. Differentiation 1984; 27: 205-208.
58. Chepenik KP, Haystead TAJ. Epidermal growth factor alters metabolism of inositol lipids and activity of protein kinase C in mouse embryo palate mesenchyme cells. J Craniofac Genet Dev Biol 1989; 9: 285-301.
59. Reddy CS. Toxicology of secalonic acid D. In Lacey J ed. Trichothecenes and other mycotoxins. New York, NY: John Wiley & Sons Ltd., 1985: 549-60.
60. Reddy CS, Hayes AW, Williams WL, Ceigler A. Toxicity of secalonic acid D. J Toxicol Environ Health 1979; 5: 1159-69.
61. Donham KJ, Hazardous agents in agricultural dusts and methods of evaluation. Am J Ind Med 1986; 10: 205-20.
62. Grain Quality Newsletter. Health hazards of dust and pesticides. Grain Quality Newslett 1983; 5: 3.
63. US Census Bureau. Statistical Abstract of the United States, 124th Ed. US Department of Commerce. Washington DC. 2004: 131-132.
64. Steyn PS. The isolation, structure and abslute configuration of secalonic acid D, the toxic metabolite of Penicillium Oxalicum. Tetrahedron 1970; 26: 51-57.
65. Reddy RV, Bouchard GF, Johnson G, Reddy CS. Disruption of epidermal growth factor signalling in the mouse palate by secalonic acid D: an in vivo study. Toxic Subst Mechanism J 1998; 17: 19-31.
66. Wang BH, Polya GM. The fungal teratogen secalonic acid D is an inhibitor of protein kinase C and of cyclic AMP-dependent protein kinase. Planta Medica 1996; 62: 111-14.
67. Pala I, Sreenivasan A, Vig PJS, Desaiah D. Modulation of calmodulin and protein kinase C activities by Penicillium mycotoxins. Int J Toxicol 1999; 18: 91-96.
68. Balasubramanian G, Reddy CS. Novel mechanism of protein kinase C inhibition involving the pseudosubstrate region by secalonic acid D. Toxicol Appl Pharmacol 2000; 163: 86-93.
69. Hanumegowda UM, Dhulipala VC, Reddy CS. Mechanism of secalonic acid D-induced inhibition of transcription factor binding to cyclic AMP response element in developing murine palate. Toxicol Sci 2002; 70: 55-62.
70. Balasubramanian G, Amann JF, Reddy CS. Expression and activity of protein kinase C isozymes during normal and abnormal murine palate development. J Craniofac Genet Dev Biol 2000; 20: 26-34.
71. Cacace AM, Guadagno SN, Krauss RS, Fabbro D, Weinstein IB. The epsilon isoform of protein kinase C is an oncogene when overexpressed in rat fibroblasts. Oncogene 1993; 8: 2095-104.
72. Saido TC, Mizuno K, Konno Y, Osada S, Ohno S, Suzuki K. Purification and characterization of protein kinase C ε from rabbit brain. Biochemistry 1992; 31: 482-90.
73. Gschwendt M, Kittstein W, Johannes F-J. Differential effects of suramin on protein kinase C isozymes. A novel tool for discriminating protein kinase C activities. FEBS Lett 1998; 421: 165-68.
74. Balasubramanian G, Hanumegowda UM, Reddy CS. Secalonic acid D alters the nature and inhibits the binding of the transcription factors to the phorbol 12-O-tetradecanoate-13-acetate (TPA)-response element in the developing murine secondary palate. Toxicol Appl Pharmacol 2000; 169: 142-50.
75. Hanumegowda UM, Balasubramanian G, Reddy CS. Secalonic acid D alters the phosphorylation of transcription factors and their binding to cAMP response element in developing murine secondary palate. Journal of Craniofac Genet Dev Biol 2001; 20: 173-82.
76. Greene RM, Lloyd MR, Uberti M, Nugent P, Pisano MM. Patterns of cyclicAMP-dependent protein kinase gene expression during ontogeny of the murine palate. J Cell Physiol 1995; 163: 431-40.
77. Don J, Stelzer G. The expanding family of CREB/CREM transcription factors that are involved with spermatogenesis. Molec Cell Endocrinol 2002; 187: 115-24.
78. Buttyan R, Zakeri Z, Lockshin R, Wolgemuth D. Cascade induction of c-fos, c-myc, and heat shock 70K transcripts during regression of the rat ventral prostrate gland. Molec Endocrinol 1988; 2: 650-57.
79. Marti A, Jehn B, Costello E, Keon N, Ke G, Martin F, Jaggi R. Protein kinase A and AP-1 (c-Fos/JunD) are induced during apoptosis of mouse mammary epithelial cells. Oncogene 1994; 9: 1213-23.
80. Abbott BD, Birnbaum LS. TCDD-induced altered expression of growth factors may have a role in producing cleft palate and enhancing the incidence of clefts after coadministiation of retinoic acid and TCDD. Toxicol Appl Pharmacol 1990; 106: 418-32.
81. Natsume N, Kawai T, Le H. In Vietnam, many congenital anomalies are believed to result from the scattering of defoliants, including dioxin. [Letter]. Cleft Palate-Craniofac J 1998; 35: 183.
82. Schardein LL. Chemically-induced birth defects. New York, NY: Marcel Dekker, 1985.
83. Degitz SJ, Francis BM, Foley GM. Mesenchymal changes associated with retinoic acid induced cleft palate in CD1 mice. J Craniofac Genet Dev Biol 1998; 18: 88-99.
84. Takagi TN, Matsui KA, Yamashita K, Ohmori H, Yasuda M. Pathogenesis of cleft palate in mouse embryos exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Teratog Carcinog Mutagen 2000; 20: 73-86.
85. Birnbaum LS, Harris MW, Stocking LM, Clark AM, Morrissey RE. Retinoic acid and TCDD selectively enhance teratogenesis in C57BL/6N mice. Toxicol Appl Pharmacol 1989; 98: 487-500.
86. Abbott BD, Harris MW, Birnbaum LS. Comparisons of the effects of TCDD and hydrocortisone on growth factor expression provide insight into their interaction in the embryonic mouse palate. Teratology 1992; 45: 35-53.
87. Abbott BD. Review of the interaction between TCDD and glucocorticoids in embryonic palate. Toxicology 1995; 105: 365-73.
88. Abbott BD, Schmid JE, Brown JG, Wood CR, White RD, Buckalew AR, Held GA. RT-PCR quantification of AHR, GR, and CYP1A1 mRNA in craniofacial tissues of embryonic mice exposed to TCDD and hydrocortisone. Toxicol Sci 1999; 47: 76-85.
89. Gambone CJ, Hutcheson JM, Gabriel JL, Beard RL, Chandraratna RA, Soprano K et al. Unique property of some synthetic retinoids: activation of the Ah receptor pathway. Molec Pharmacol 2002; 61: 334-42.
90. Medh RD, Schmidt TJ. Trans-retinoic acid and glucocorticoids synergistically induce transcription from the mouse mammary tumor virus promoter in human embryonic kidney cells. J Steroid Biochem Molec Biol 1997; 62: 129-42.
91. Cho Y, Tighe AP, Talmage DA. Retinoic acid induced growth arrest of human breast carcinoma cells requires protein kinase C alpha expression and activity. J Cell Physiol 1997; 172: 306-13.
92. Sosnowski J, Stetter-Neel C, Cole D, Durham JP, Mahwinney MG et al. Protein kinase C mediated anti-proliferative glucocorticoid-sphinganine synergism in cultured Pollard III prostate tumor cells. J Urol 1997; 158: 269-74.
93. Weber TJ, Chapkin RS, Davidson LA, Ramos KS. Modulation of protein kinase C-related signal transduction by 2,3,7,8-tetrachlorodibenzo-p-dioxin exhibits cell cycle dependence. Arch Biochem Biophys 1996; 328: 227-32.
94. Rochette-Egly C. Phosphorylation of the retinoic acid receptor-alpha by protein kinase A. Molec Endocrinol 1995; 9: 860-71.
95. Reddy CS. Alterations in protein kinase A signalling and cleft palate: a review. Hum Exp Toxicol 2005; 24: 235-42.